A randomized, double-blind trial comparing the effect of fluticasone/salmeterol 250/50 to salmeterol on COPD exacerbations in patients with COPD

被引：0
|
作者：
Ferguson, Gary [1 ]
Anzueto, Antonio [1 ]
Fei, Richard [1 ]
Emmett, Amanda [1 ]
Crater, Glenn [1 ]
Knobil, Kate [1 ]
Kalberg, Chris [1 ]
机构：
[1] Pulm Res Inst SE Michigan, Livonia, MI USA
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：530S / 531S
页数：2
相关论文
共 50 条
  • [21] Efficacy of Advair Diskus 250/50 (fluticasone propionate/salmeterol) or ipratropium/albuterol in patients with COPD associated with chronic bronchitis and/or emphysema
    Sciurba, FC
    Kalberg, C
    Emmett, A
    Merchant, K
    Brown, C
    Knobil, K
    CHEST, 2004, 126 (04) : 807S - 808S
  • [22] Childhood evaluation of salmeterol tolerance - A double-blind randomized controlled trial
    Carroll, W. D.
    Jones, P. W.
    Boit, P.
    Clayton, S.
    Cliff, I.
    Lenney, W.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2010, 21 (02) : 336 - 344
  • [23] COPD-Related Outcomes And Costs For Patients On Combination Fluticasone Propionate/Salmeterol 250/50mcg Versus Anticholinergics In A Comorbid COPD/Depression Population
    Dalal, A. A.
    Shah, M.
    D'Souza, A. O.
    Chaudhari, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [24] Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD
    O'Donnell, Denis E.
    Sciurba, Frank
    Celli, Bartolome
    Mahler, Donald A.
    Webb, Katherine A.
    Kalberg, Chris J.
    Knobil, Katharine
    CHEST, 2006, 130 (03) : 647 - 656
  • [25] Survival in COPD patients after regular use of fluticasone propionate and salmeterol
    Soriano, JB
    Vestbo, J
    Pride, NB
    EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (03) : 560 - 560
  • [26] Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study
    Sharafkhaneh, Amir
    Southard, John G.
    Goldman, Mitchell
    Uryniak, Tom
    Martin, Ubaldo J.
    RESPIRATORY MEDICINE, 2012, 106 (02) : 257 - 268
  • [27] LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD
    Zhong, Nanshan
    Wang, Changzheng
    Zhou, Xiangdong
    Zhang, Nuofu
    Humphries, Michael
    Wang, Linda
    Thach, Chau
    Patalano, Francesco
    Banerji, Donald
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1015 - 1026
  • [28] INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD
    Rossi, Andrea
    van der Molen, Thys
    del Olmo, Ricardo
    Papi, Alberto
    Wehbe, Luis
    Quinn, Matthew
    Lu, Chengxing
    Young, David
    Cameron, Ray
    Bucchioni, Enrica
    Altman, Pablo
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (06) : 1548 - 1556
  • [29] Generic Vs. Brand-name Fluticasone-Salmeterol in the Prevention of COPD Exacerbations
    Feldman, W. B.
    Kesselheim, A.
    Avorn, J.
    Wang, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [30] INSTEAD: Randomized switch trial of indacaterol and salmeterol/ fluticasone combination (SFC) in moderate COPD: Symptoms results
    Rossi, Andrea
    Van der Molen, Thys
    Del Olmo, Ricardo
    Papi, Alberto
    Wehbe, Luis
    Quinn, Matthew
    Lu, Chengxing
    Young, David
    Cameron, Ray
    Altman, Pablo
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
12345